(Q40423784)

20 September 2017

Reorganization of ErbB family and cell survival signaling after Knock-down of ErbB2 in colon cancer cells (English)

1 reference

20 September 2017

1 reference

Yi Peter Hu

1

1 reference

20 September 2017

Srinivas Venkateswarlu

2

1 reference

20 September 2017

Natalia Sergina

3

1 reference

20 September 2017

Gillian Howell

4

1 reference

20 September 2017

Patricia St Clair

5

1 reference

20 September 2017

Lisa E Humphrey

6

1 reference

20 September 2017

Wenhui Li

7

1 reference

20 September 2017

Jennie Hauser

8

1 reference

20 September 2017

Elizabeth Zborowska

9

1 reference

20 September 2017

James K V Willson

10

1 reference

20 September 2017

Michael G Brattain

11

1 reference

20 September 2017

language of work or name

English

0 references

publication date

11 May 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

29

1 reference

20 September 2017

27383-27392

1 reference

Growth factor signaling by receptor tyrosine kinases

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Differentially expressed genes in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Specificity within the EGF family/ErbB receptor family signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Tyrosine kinase signalling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Signal transduction and oncogenesis by ErbB/HER receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Essential roles of Her2/erbB2 in cardiac development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Heterogeneity of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Cloning of mammalian Ire1 reveals diversity in the ER stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the hum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Structural analysis of the epitopes on erbB2 interacted with inhibitory or non-inhibitory monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Current status of antibody therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414238200

21 January 2018

Identifiers

DOI

10.1074/JBC.M414238200

1 reference

20 September 2017

1 reference